Clinical Trial Update: Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine [NA]

View source ↗

Summary

A clinical trial investigating whether green tea can prevent olanzapine-associated weight gain and dyslipidemia in patients with bipolar disorder or schizophren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Green tea
• olanzapine (olanzapine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Bipolar Disorder, Schizophrenia | NA | Status: WITHDRAWN